Wire · opportunities
Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 7 August 2026 · Fusion42 review
The FDA approved the first drug to treat the full range of narcolepsy type 1 symptoms and also approved Moderna's mRNA flu vaccine, marking significant regulatory advancements in neurology and vaccine technology in the United States.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
You must update product roadmaps and clinical plans now as FDA approval opens a new therapeutic market for type 1 narcolepsy and validates mRNA vaccine technology in flu targeting. These regulatory greenlights lift barriers and attract investment into biotech therapies focused on neurological and infectious diseases.
◆ Coverage
1 source · 6 Aug 2026
◆ Related on Wire
◆ Topics